PCE is pleased to announce the launch of the 2026 Edition of the Early Career Investigator (ECI) Short-term Scientific Stay Award. This initiative aims to support the next generation of… …Read More »PCE Launches the 2026 Early Career Investigator Short-term Scientific Stay Award
PCE is pleased to announce a new collaboration with CureWiki, aimed at improving access to reliable and up-to-date clinical trial information for patients and carers across Europe. As part of… …Read More »Pancreatic Cancer Europe collaborates with CureWiki to improve access to clinical trial information
On 28 April 2026, Pancreatic Cancer Europe hosted a high-level public awareness event in Valletta, titled “Pancreatic cancer: how to make a difference for the next decade.” Delivered with the support of the Ministry for Health and Active… …Read More »Pancreatic Cancer Europe Showcases 10 Years of Impact at Public Awareness Event in Valletta
Valletta, Malta | 27 April 2026 Pancreatic Cancer Europe (PCE) marked its 10th Anniversary with the delivery of an exclusive, invitation-only masterclass titled “Pancreatic Cancer: a comprehensive overview on latest developments”, held in Valletta, Malta, with… …Read More »Pancreatic Cancer Europe marks 10th Anniversary with exclusive masterclass in Malta, supported by the Ministry for Health and Active Ageing
Celebrating 10 Years of Progress in Pancreatic Cancer We are proud to mark a major milestone — 10 years of progress, collaboration, and impact in the fight against pancreatic cancer. To celebrate,… …Read More »“10 Years. 10 Voices. One Future.”
Brussels, 18 February 2026 — Pancreatic Cancer Europe (PCE) marks its 10th anniversary, reflecting on a decade of work to improve awareness, advocacy, and care for people affected by pancreatic… …Read More »Press Release: Pancreatic Cancer Europe marks 10 years of advocacy and calls for action on early detection
In 2026, Pancreatic Cancer Europe (PCE) marks 10 years of European collaboration dedicated to raising awareness and improving care for people affected by pancreatic cancer. Since its establishment in 2016, PCE has brought together patient organisations, healthcare… …Read More »Pancreatic Cancer Europe Marks 10 Years in 2026
PCE is pleased to announce that it has become a member of the European Liquid Biopsy Society (ELBS), a multidisciplinary network dedicated to advancing the clinical implementation of liquid biopsy… …Read More »PCE becomes a member of the European Liquid Biopsy Society (ELBS)
PCE is pleased to announce the launch of the Treatment Opportunities and Pancreatic Cancer booklet, a new resource created to support patients and carers from diagnosis through treatment and beyond. Treatments… …Read More »PCE is pleased to announce the launch of the Treatment Opportunities and Pancreatic Cancer booklet
PCE is proud to spotlight the newly launched Digestive Health Manifesto, developed through the Digestive Health Roundtable that took place on October 5 during the UEG Week 2025 in close… …Read More »PCE Highlights the Launch of the Digestive Health Manifesto
As part of Pancreatic Cancer Awareness Month 2025, Pancreatic Cancer Europe delivered an educational campaign focused on improving understanding of clinical trials. Through a series of clear, patient-friendly Q&A resources, the… …Read More »Pancreatic Cancer Awareness Month Campaign 2025
In May 2024, the Position Paper on “Pancreatic Cancer Across Europe” was shared with candidates to the European Parliament, highlighting seven key action points to improve prevention, early detection, research,… …Read More »Pancreatic Cancer Across Europe: Continuing the Momentum After the 2024 EU Elections
A PCE and EPC Initiative for the 2025 World Pancreatic Cancer Awareness Month Date: Thursday, 27 November 2025Time: 15:30–17:00 CETLocation: Online About the Event PCE and the European Pancreatic Club (EPC) are proud… …Read More »Save the date and register: Clinical trials for innovative pancreatic cancer treatments, online webinar
PCE is proud to announce its membership in the Trans-Atlantic Pancreatic Cancer Alliance (TAPCA), a pioneering initiative that, for the first time, brings together leading Pancreatic Ductal Adenocarcinoma (PDAC) investigators from across the… …Read More »PCE proudly joins the Trans-Atlantic Pancreatic Cancer Alliance (TAPCA)
PCE is pleased to announce a new collaboration with OncoSil Medical as part of the ‘Treatment Opportunities for Pancreatic Cancer‘ project. The initiative aims to raise awareness of innovative therapies, address… …Read More »Pancreatic Cancer Europe and OncoSil Medical Join Forces to Improve Treatment Opportunities for Patients
The Role of HTA in National Healthcare: Bridging Policy and Patient AccessDate: 14 October 2025Time: 15:30 – 17:00 CESTFormat: Online Webinar PCE, in collaboration with Cancer Patients Europe (CPE), is pleased to invite… …Read More »Upcoming Webinar: The Role of HTA in National Healthcare: Bridging policy and patient access
PCE, in collaboration with the European Pancreatic Club (EPC) and the European Oncology Nursing Society (EONS), is pleased to announce an upcoming webinar for healthcare professionals on the role of… …Read More »Mastering Patient Care: Physical activity and pancreatic cancer, a webinar for healthcare professionals
PCE is pleased to announce a new strategic partnership with Magle Pharmacept, part of the Magle Group, aimed at improving treatment opportunities and outcomes for people affected by pancreatic cancer. As… …Read More »PCE and Magle Pharmacept Join Forces to Improve Pancreatic Cancer Treatment Opportunities
PCE is proud to announce the launch of a new project titled “The Importance of Information on Pancreatic Cancer for the General Public in Belgium”, which is now officially underway… …Read More »PCE Project receives support from Loterie Nationale
Pancreatic Cancer Europe (PCE) is pleased to announce the composition of its new Board of Directors, a dedicated group of professionals and patient advocates committed to advancing pancreatic cancer research,… …Read More »Pancreatic Cancer Europe Announces New Board
Date: 15 January 2025Time: 14:30 – 16:30 CETLocation: European Parliament, Brussels, Belgium Event Overview A pivotal stakeholder dialogue event will take place under the auspices of the PANCAID project, specifically within the framework… …Read More »Upcoming Event: PANCAID’s First Stakeholder Event
The Position: Fundraiser PCE is looking for a skilled and motivated Fundraiser to join its team. In this role, the Fundraiser will be responsible for identifying fundraising opportunities, developing relationships with potential… …Read More »PCE is Hiring a Fundraiser – Apply Now!
Introducing Our New Nutrition Project Videos! PCE, with the support of the Medical Nutrition International Industry Association (MNI), is thrilled to announce the launch of a video series dedicated to… …Read More »PCE and MNI Present: Nutrition Project Videos
Date: 28 November 2024Time: 15:00 – 16:30 CET Join our upcoming webinar on ‘Emotional Support and Pancreatic Cancer’, in cooperation with the European Pancreatic Club (EPC), taking place on 28 November 2024 from… …Read More »Emotional Support and Pancreatic Cancer Webinar, 28 November 2024, 15:00 – 16:30 CET
In an advancement for pancreatic cancer care, PCE is excited to announce a new partnership with myTomorrows. This collaboration aims to improve access to clinical trials and expand treatment options… …Read More »New Partnership: Pancreatic Cancer Europe and myTomorrows Join Forces to Improve Clinical Trial Access
About the Call to Action The new EU Joint Clinical Assessment (JCA) will become an additional barrier for patient access to advanced therapies if the Health Technology Assessment (HTA) Coordination… …Read More »Call to Action of Concerned Stakeholders on the implementation of the EU HTA and Joint Clinical Assessment for ATMPs
On June 27, 2024, stakeholders gathered in Santiago de Compostela, Spain, for a discussion on the findings of the PancreOS Project, hosted by PCE with the support of the European… …Read More »First results of the PancreOS Project: Roundtable on gaps and fragmentation of pancreatic cancer patients’ management in Europe
